Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High fees hinder European patents:

This article was originally published in Clinica

Executive Summary

High administration and translation fees are discouraging European companies from filing patents, reveals a survey by the European Patent Office in Munich (Germany). The EPO is keen to reduce the costs of patenting, particularly as small- and medium-sized companies have filed ever fewer patents in recent years. Fees are lower in the US (USPTO), Japan (JPO) and through national patent offices in Europe. The average cost of an EPO patent, including translation and administration fees is DM 45,510 ($32,000) says Nature (May 25th, 1995).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091857

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel